“…Interestingly, TNTs have been implicated in both inflammation (Jiang et al ., 2016; Weng et al ., 2016; Ariazi et al ., 2017; Nawaz and Fatima, 2017; Weidle et al ., 2018; Yao et al ., 2018; Kuret et al ., 2019; Mittal et al ., 2019a) and angiogenesis (Figeac et al ., 2014; Climent et al ., 2015; Patheja and Sahu, 2017; Errede et al ., 2018; Lou et al ., 2018; Liu et al ., 2019), indicating that CD13 may be upregulated specifically to participate in these processes, possibly by promoting TNT formation and function. We have also determined that during inflammation, activation of CD13 on endothelial cells increases monocyte adhesion and transmigration (Mina-Osorio et al ., 2008; Subramani et al ., 2013; Ghosh et al ., 2014; Rahman et al ., 2014a; Rahman et al ., 2014b), which may relate to “transmigratory cups” or “endothelial adhesive platforms” which are actin-based, TNT-like docking protrusions that form at the site of inflammatory leukocyte extravasation to mediate the adhesion phase of immune infiltration (Carman et al ., 2003; Carman and Springer, 2004; Riethmuller et al ., 2008; Wittchen, 2009; Vestweber et al ., 2013; Franz et al ., 2016; Johnson et al ., 2017; Genna et al ., 2023). In support of this notion, we have found that endothelial CD13 is highly enriched in similar protrusions formed between monocytes and endothelial cells in vitro (Mina-Osorio et al ., 2008).…”